Ryan Ziffra

Senior Scientist II at Scribe Therapeutics

Ryan Ziffra is a seasoned professional in the biotech field, currently serving as Program Director of Platform Development and Lead Scientist at Regel Therapeutics since February 2021. Prior experience includes key roles at EVEXIA Bio Fund as Partner and VP of Finance, managing fund finances and conducting trades, as well as leadership positions at Biotech Connection - Bay Area, Inc., where Ryan acted as President and Project Manager. Academic credentials include a PhD in Biomedical Sciences from the University of California, San Francisco, alongside a Bachelor of Medical Science from Dominican University and a Bachelor of Science in Business Administration from DePaul University. Ryan's research background encompasses work on gene regulatory landscapes and genomics related to preterm birth, reflecting a strong foundation in both scientific inquiry and financial management within biotechnology.

Location

Pleasant Hill, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Scribe Therapeutics

1 followers

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.


Employees

51-200

Links